<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>GekkoWire</title>
	<atom:link href="http://www.gekkowire.com/?feed=rss2" rel="self" type="application/rss+xml" />
	<link>http://www.gekkowire.com</link>
	<description>A blog for small pharma investing</description>
	<lastBuildDate>Wed, 08 Sep 2010 18:08:35 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Avanir Pharmaceuticals (AVNR): All About The QTc Intervals</title>
		<link>http://www.gekkowire.com/?p=4796</link>
		<comments>http://www.gekkowire.com/?p=4796#comments</comments>
		<pubDate>Wed, 08 Sep 2010 16:07:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[AVNR]]></category>

		<guid isPermaLink="false">http://www.gekkowire.com/?p=4796</guid>
		<description><![CDATA[




Avanir QTc Intervals
So I have had a lot of questions about AVP-923 and whether or not I think the drug will get the approval nod. But I also get a lot of questions about what QT intervals are and why they are so important to Avanir.




 In January 2006, Avanir submitted an expanded NDA for [...]]]></description>
		<wfw:commentRss>http://www.gekkowire.com/?feed=rss2&amp;p=4796</wfw:commentRss>
		<slash:comments>14</slash:comments>
		</item>
		<item>
		<title>Cell Therapeutics Pleas With Investors for Vote</title>
		<link>http://www.gekkowire.com/?p=4792</link>
		<comments>http://www.gekkowire.com/?p=4792#comments</comments>
		<pubDate>Wed, 08 Sep 2010 14:51:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[CTIC]]></category>

		<guid isPermaLink="false">http://www.gekkowire.com/?p=4792</guid>
		<description><![CDATA[




Cell Therapeutics (CTIC) Pleas With Investors for Vote
In a rare move, Cell Therapeutics filed what I call a personal appeal letter with the SEC on 9/3/2010 pleading with investors to answer their proxy filings. The last four times Cell’s management tried to convene Special Meetings they could not get enough of the shareholders to agree [...]]]></description>
		<wfw:commentRss>http://www.gekkowire.com/?feed=rss2&amp;p=4792</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>Daily Pharma Watch (Update in Progress)</title>
		<link>http://www.gekkowire.com/?p=4790</link>
		<comments>http://www.gekkowire.com/?p=4790#comments</comments>
		<pubDate>Wed, 08 Sep 2010 13:46:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[ONXX]]></category>
		<category><![CDATA[YMI]]></category>

		<guid isPermaLink="false">http://www.gekkowire.com/?p=4790</guid>
		<description><![CDATA[Onyx Pharmaceuticals (ONXX):
This morning Onyx Pharmaceuticals said that they have sold the Japanese rights of carfilzomib and ONX192 to Ono Pharmaceuticals for a $59 million upfront payment and potential backend sales based payments related to the drugs that could total up to $280 million. Carfilzomib recently showed strong results in a Phase IIb study in [...]]]></description>
		<wfw:commentRss>http://www.gekkowire.com/?feed=rss2&amp;p=4790</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MELA Sciences&#8217; MELAFind Part I</title>
		<link>http://www.gekkowire.com/?p=4777</link>
		<comments>http://www.gekkowire.com/?p=4777#comments</comments>
		<pubDate>Tue, 07 Sep 2010 19:59:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[MELA]]></category>

		<guid isPermaLink="false">http://www.gekkowire.com/?p=4777</guid>
		<description><![CDATA[MELA’s MELAFind
A lot of MELA investors have emailed in for me to do a piece on Mela, so I have decided to do a two part piece on their MELAFind technology. In the first part I’ll go through the Device approval process because it is actually very different than the drug approval process. And I’ll [...]]]></description>
		<wfw:commentRss>http://www.gekkowire.com/?feed=rss2&amp;p=4777</wfw:commentRss>
		<slash:comments>5</slash:comments>
		</item>
		<item>
		<title>New Research and Developments Tax Credits Could Be Good For Pharma</title>
		<link>http://www.gekkowire.com/?p=4774</link>
		<comments>http://www.gekkowire.com/?p=4774#comments</comments>
		<pubDate>Tue, 07 Sep 2010 17:10:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.gekkowire.com/?p=4774</guid>
		<description><![CDATA[New Research and Developments Tax Credits Could Be Good For Pharma 
Investors in pharma companies may get a boost on Thursday morning. Why? On Wednesday night in Cleveland President Obama is expected to announce a series of new tax credits designed to help the economy. It appears that R&#038;D, the lifeblood of pharma companies, is [...]]]></description>
		<wfw:commentRss>http://www.gekkowire.com/?feed=rss2&amp;p=4774</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Intermune (ITMN) Update: Company Needs Another Clinical Trial</title>
		<link>http://www.gekkowire.com/?p=4770</link>
		<comments>http://www.gekkowire.com/?p=4770#comments</comments>
		<pubDate>Tue, 07 Sep 2010 16:32:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Itmn]]></category>

		<guid isPermaLink="false">http://www.gekkowire.com/?p=4770</guid>
		<description><![CDATA[Intermune (ITMN) Update: Company Needs Another Clinical Trial 
I have gotten quite a few questions about Intermune over the past couple of weeks, so I have decided to provide a brief update on the company. 
The last time I wrote a post on Intermune (article here), it was a couple of days before the company [...]]]></description>
		<wfw:commentRss>http://www.gekkowire.com/?feed=rss2&amp;p=4770</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Daily Pharma Watch (Update in Progress)</title>
		<link>http://www.gekkowire.com/?p=4763</link>
		<comments>http://www.gekkowire.com/?p=4763#comments</comments>
		<pubDate>Tue, 07 Sep 2010 14:26:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[BMOD]]></category>
		<category><![CDATA[cytr]]></category>
		<category><![CDATA[GNBT]]></category>
		<category><![CDATA[IDIX]]></category>
		<category><![CDATA[RNN]]></category>

		<guid isPermaLink="false">http://www.gekkowire.com/?p=4763</guid>
		<description><![CDATA[Idenix Pharmaceuticals (IDIX):
Bad news for Idenix this morning, in a press release the company announced that the company “received verbal notice on Friday, September 3, 2010 from the U.S. Food and Drug Administration (FDA) that the IDX184 and IDX320 programs have been placed on clinical hold.” The FDA decided to put a hold was placed [...]]]></description>
		<wfw:commentRss>http://www.gekkowire.com/?feed=rss2&amp;p=4763</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Celldex (CLDX): CDX-110, Pfizer Walks Away: Another Blunder by Pfizer?</title>
		<link>http://www.gekkowire.com/?p=4751</link>
		<comments>http://www.gekkowire.com/?p=4751#comments</comments>
		<pubDate>Fri, 03 Sep 2010 13:27:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[CLDX]]></category>

		<guid isPermaLink="false">http://www.gekkowire.com/?p=4751</guid>
		<description><![CDATA[Celldex Rundown
So this morning Pfizer said they were going to walk away from the development agreement with Celldex. This has led some to speculate whether or not Pfizer missed the boat again, is CDX-110 too hard to develop, or does it not show strong efficacy.  I’ll be honest, I didn’t really like the deal [...]]]></description>
		<wfw:commentRss>http://www.gekkowire.com/?feed=rss2&amp;p=4751</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Avanir Pharmaceuticals (AVNR) Shelf Filing for $75 Million (New PPS Estimate)</title>
		<link>http://www.gekkowire.com/?p=4749</link>
		<comments>http://www.gekkowire.com/?p=4749#comments</comments>
		<pubDate>Fri, 03 Sep 2010 13:22:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[AVNR]]></category>

		<guid isPermaLink="false">http://www.gekkowire.com/?p=4749</guid>
		<description><![CDATA[Avanir Pharmaceuticals (AVNR) Shelf Filing for $75 Million 
In an SEC S-3 filing late yesterday Avanir said that they could possibly raise up to $75 million more in capital raises (filing here). I would estimate that the company is going to raise anywhere from $20-30 million more in capital before their lead product AVP-923’s PDUFA [...]]]></description>
		<wfw:commentRss>http://www.gekkowire.com/?feed=rss2&amp;p=4749</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Sunesis Pharmaceuticals (SNSS) Shelf Filing</title>
		<link>http://www.gekkowire.com/?p=4744</link>
		<comments>http://www.gekkowire.com/?p=4744#comments</comments>
		<pubDate>Thu, 02 Sep 2010 20:46:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[snss]]></category>

		<guid isPermaLink="false">http://www.gekkowire.com/?p=4744</guid>
		<description><![CDATA[A lot of Sunesis investors have emailed me about the recent Effectiveness order by the SEC for their recent S-3 amendment, Effectiveness order was filed yesterday. I have had a lot of questions asking whether or not this filing would spell more dilution for current shareholders. And the answer is NO, and here’s why.

There has [...]]]></description>
		<wfw:commentRss>http://www.gekkowire.com/?feed=rss2&amp;p=4744</wfw:commentRss>
		<slash:comments>5</slash:comments>
		</item>
	</channel>
</rss>
